pancaspase inhibitor z vad fmk z val ala asp ome fmk (Valiant Co Ltd)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Valiant Co Ltd pancaspase inhibitor z vad fmk z val ala asp ome fmk
Pancaspase Inhibitor Z Vad Fmk Z Val Ala Asp Ome Fmk, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 96/100, based on 24 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/03fk01601/Z-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethylketone/pmc03270278-135-1-5
Average 96 stars, based on 24 article reviews

pancaspase inhibitor z vad fmk z val ala asp ome fmk - by Bioz Stars, 2026-09

96/100 stars

Images

other:

Article Title: Rare human Caspase-6-R65W and Caspase-6-G66R variants identify a novel regulatory region of Caspase-6 activity
Article Snippet: Casp6 and Casp3 active site concentrations (Supplementary Fig. ) were determined using irreversible inhibitor zVAD-FMK (N-benzyloxycarbonyl-Val-Ala-Asp-(O-methyl)-fluoromethylketone, MP Biomedicals, Santa Ana, CA, USA) .

Article Title: Identification of Allosteric Inhibitors against Active Caspase-6
Article Snippet: Casp6 active sites were quantified using zVAD-FMK (N-benzyloxycarbonyl-Val-Ala-Asp-(O-methyl)-fluoromethylketone, MP Biomedicals, Santa Ana, CA, USA) , .

Article Title: Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells.
Article Snippet: The pancaspase inhibitor z-VAD-FMK (z-Val-Ala-Asp(OMe)-FMK) (MP Biomedicals, Illkirch, France) was used at 10mM, 3-methyladenine (3-MA) (Sigma-Aldrich, Stockholm, Sweden) was used at 5 mM, Necrostatin1 (Sigma-Aldrich) was used at 50 mM, Chloroquine (Sigma-Aldrich Sweden AB, Stockholm, Sweden) at 10 mM, ABT737 (active biochemical Co. Hong Kong, PR China) at 10mM, Rapamycin at 1 mM, U0126 (Sigma-Aldrich) at 10mM, LY294002 (Sigma-Aldrich) at10 mM.

Article Title: Sorafenib-induced defective autophagy promotes cell death by necroptosis.
Article Snippet: Pancaspase inhibitor z-VAD-FMK (z-Val-AlaAsp(OMe)-FMK) (FK009), Z-LEHD-FMK (Z-LeuGlu(OMe)-His-Asp(OMe)-FMK) (FK022) from MP Biomedicals used at 10 μM, Rapamycin (R8781) used at 1 μM, Bafilomycin A1 (Sigma-Aldrich, B1793) used at 10 nM, Chloroquine (PHR1258) used at 50 μM, LY294002 (Sigma-Aldrich, L9908) used at 10 μM, Necrostatin-1 (Sigma-Aldrich, N9037) used at 50 μM, and Oligomycin A at 2.5 μg/ml (Sigma-Aldrich, 75351).

Article Title: Caspase signalling controls microglia activation and neurotoxicity.
Article Snippet: Activation of microglia and inflammation-mediated neurotoxicity are suggested to play a decisive role in the pathogenesis of several neurodegenerative disorders.. Activated microglia release pro-inflammatory factors that may be neurotoxic.. Here we show that the orderly activation of caspase-8 and caspase-3/7, known executioners of apoptotic cell death, regulate microglia activation through a protein kinase C (PKC)-d-dependent pathway.

Concentration Assay:

Article Title: Rare CASP6 N73T variant associated with hippocampal volume exhibits decreased proteolytic activity, synaptic transmission defect, and neurodegeneration
Article Snippet: .. Casp6 active site concentration was determined using an irreversible inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-(O-methyl)-fluoromethylketone (zVAD-FMK; MP Biomedicals, Irvine, CA, USA) as described . ..

Article Title: Rare CASP6N73T variant associated with hippocampal volume exhibits decreased proteolytic activity, synaptic transmission defect, and neurodegeneration.
Article Snippet: .. Casp6 active site concentration was determined using an irreversible inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-(O-methyl)-fluoromethylketone (zVAD-FMK; MP Biomedicals, Irvine, CA, USA) as described46. ..

Transduction:

Article Title: Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells
Article Snippet: .. The pancaspase inhibitor z-VAD-FMK (z-Val-Ala-Asp(OMe)-FMK) (MP Biomedicals, Illkirch, France) was used at 10 μ M, 3-methyladenine (3-MA) (Sigma-Aldrich, Stockholm, Sweden) was used at 5 mM, Necrostatin1 (Sigma-Aldrich) was used at 50 μ M, Chloroquine (Sigma-Aldrich Sweden AB, Stockholm, Sweden) at 10 μ M, ABT737 (active biochemical Co. Hong Kong, PR China) at 10 μ M, Rapamycin at 1 μ M, U0126 (Sigma-Aldrich) at 10 μ M, LY294002 (Sigma-Aldrich) at10 μ M. The primary antibodies used in this study pSrc (Y416), Src, MEK1, phospho-ERK1/2 (Thr202/Tyr204), ERK1/2 PTEN, cleaved caspase-3, cleaved caspase-7, cleaved-PARP, phosphor-AKT (Ser473), AKT, pBAD (Ser112), BAD, ATG-5, Mcl-1, LC3 I/II, Bcl-2, PDGFR β , phosphoY705 STAT3 and STAT3 were obtained from Cell Signaling Technology (Danvers, MA, USA), p62 from Abnova (Heidelberg, Germany), Bim from Stressgene (Plymouth Meeting, PA, USA), Bcl-xL from Transduction Laboratories (Franklin Lakes, NJ, USA), GAPDH and N-cadherin from Abcam (Cambridge, UK), β -actin from Sigma-Aldrich, Bak, Bax, E-cadherin, vimentin from BD Biosciences, AIF from Santa Cruz Biotechnology (Heidelberg, Germany). .. Transfection with plasmids and siRNA experiments where performed according to protocols provided by Invitrogen (Stockholm, Sweden).

Review

pancaspase inhibitor z vad fmk z val ala asp ome fmk (Valiant Co Ltd)

Structured Review

Images

Related Articles

other:

Concentration Assay:

Transduction:

Similar Products

Image Search Results